Royce & Associates’s Vascular Solutions Inc VASC Stock Holding History

Royce & Associates’s Portfolio VASC Stock Details VASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-114,485	Closed	-$3.94M	–	1161
2015 Q4	$3.94M	Sell	114,485 -40,965	-26%	-$1.39M	0.02%	688
2015 Q3	$5.04M	Sell	155,450 -8,050	-5%	-$288K	0.03%	642
2015 Q2	$5.68M	Sell	163,500 -9,800	-6%	-$320K	0.02%	704
2015 Q1	$5.25M	Sell	173,300 -17,000	-9%	-$488K	0.02%	736
2014 Q4	$5.17M	Buy	190,300 +18,900	+11%	+$513K	0.02%	781
2014 Q3	$4.23M	Hold	171,400	–	–	0.01%	854
2014 Q2	$3.8M	Buy	171,400 +30,155	+21%	+$660K	0.01%	920
2014 Q1	$3.7M	Buy	141,245 +89,245	+172%	+$2.22M	0.01%	941
2013 Q4	$1.2M	Buy	52,000 +48,400	+1,344%	+$949K	﹤0.01%	1146
2013 Q3	$60K	Hold	3,600	–	–	﹤0.01%	1395
2013 Q2	$53K	Buy	+3,600	New	+$56.6K	﹤0.01%	1377

Other funds holding VASC

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates's VASC Position: Q1 2016 in Review

Royce & Associates sold out of Vascular Solutions Inc (VASC) in Q1 2016, closing a stake of 114,485 shares — an estimated $3.94M sold.

Royce & Associates first reported a position in VASC in Q2 2013 and held it in 11 quarters. The position peaked at $5.68M in Q2 2015. 135 funds tracked by Wall St. Rank hold VASC as of Q1 2016.

Royce & Associates reported no remaining Vascular Solutions Inc position as of Q1 2016 after selling out during the quarter.
Royce & Associates sold 114,485 Vascular Solutions Inc shares in Q1 2016, an estimated $3.94M.
Royce & Associates first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 11 quarters.
Royce & Associates's Vascular Solutions Inc position peaked at $5.68M in Q2 2015.
135 funds tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2016.

Based on Royce & Associates's 13F filing for Q1 2016, filed 11 May 2016.